Latest Advances

  • Condition: Axial Spondyloarthritis (axSpA)
  • Journal: Advances in rheumatology (London, England)
  • Treatment Used: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
  • Number of Patients: 0
  • Published —
This article provides guidelines for the treatment of patients with axial spondyloarthritis (axSpA) with nonsteroidal anti-inflammatory drugs (NSAIDs).
  • Condition: Axial Spondyloarthritis
  • Journal: Rheumatology (Oxford, England)
  • Treatment Used: NSAIDs
  • Number of Patients: NULL
  • Published —
The study researched treatment of axial spondyloarthritis.
  • Condition: Axial Spondyloarthritis
  • Journal: RMD open
  • Treatment Used: Secukinumab
  • Number of Patients: 1860
  • Published —
This study explored the effectiveness of 6-month and 12-month secukinumab in patients with axial spondyloarthritis (spinal degeneration; axSpA).
  • Condition: Axial Spondyloarthritis
  • Journal: Arthritis research & therapy
  • Treatment Used: TNF Inhibitors
  • Number of Patients: 193
  • Published —
This study investigated if switching TNF inhibitors after a primary or secondary failure provides good clinical outcomes in patients with axial spondyloarthritis.
  • Condition: Axial Spondyloarthritis
  • Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
  • Treatment Used: Serial Locally Applied Water-filtered Infrared a Radiation (sl-wIRAR)
  • Number of Patients: 71
  • Published —
In this study, researchers evaluated the outcomes of using serial locally applied water-filtered infrared A radiation (sl-wIRAR) for the treatment of axial spondyloarthritis.
  • Condition: Axial Spondyloarthritis
  • Journal: Annals of the rheumatic diseases
  • Treatment Used: Secukinumab
  • Number of Patients: 390
  • Published —
This study tested the safety and efficacy of using secukinumab to treat patients with axial spondyloarthritis that have already been previously treated with TNF inhibitors.
  • Condition: Axial Spondyloarthritis
  • Journal: RMD open
  • Treatment Used: Certolizumab Pegol
  • Number of Patients: 89
  • Published —
The study researched the impact of certolizumab pegol treatment on the incidence of anterior uveitis flares in patients with axial spondyloarthritis.
  • Condition: Axial Spondyloarthritis
  • Journal: Mediators of inflammation
  • Treatment Used: Secukinumab
  • Number of Patients: 39
  • Published —
This study tested the safety and efficacy of using secukinumab to treat patients with axial spondyloarthritis.
  • Condition: Axial Spondyloarthritis (AxSpA)
  • Journal: Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan
  • Treatment Used: Qushi Xiezhuo Formula (QSXZF)
  • Number of Patients: 62
  • Published —
This study investigated the effect of Qushi Xiezhuo formula (QSXZF) on axial spondyloarthritis (autoinflammatory disease affecting the joints of the spine, chest and pelvis; AxSpA) with a high incidence of monosodium serum urate (MSU) crystal deposition (gout).
  • Condition: Radiographic Progression in Axial Spondyloarthritis
  • Journal: Arthritis & rheumatology (Hoboken, N.J.)
  • Treatment Used: Tumor Necrosis Factor Inhibitors (TNFi), Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Secukinumab
  • Number of Patients: 0
  • Published —
This review of the literature investigated the effect of therapies on radiographic progression in patients with axial spondyloarthritis (spinal arthritis; SpA).
  • Condition: Axial Spondyloarthritis
  • Journal: Journal of autoimmunity
  • Treatment Used: Treat toTarget Strategy
  • Number of Patients: 0
  • Published —
This article discusses a treat to target strategy for axial spondyloarthritis.
Showing 1-12 of 34